Your browser doesn't support javascript.
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
Hagan, Liesl M; Dusseau, Charles; Crockett, Michael; Rodriguez, Tami; Long, Michael J.
  • Hagan LM; Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Viral Hepatitis, 1600 Clifton Road NE, Atlanta, GA 30333, United States; Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, Unit
  • Dusseau C; Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: cdusseau@bop.gov.
  • Crockett M; Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: mcrockett@bop.gov.
  • Rodriguez T; Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: t1rodriguez@bop.gov.
  • Long MJ; Federal Bureau of Prisons, Health Services Division, 320 First Street NW, Washington, DC 20534, United States; Commissioned Corps of the United States Public Health Service, 1101 Wootton Pkwy, Plaza level, Rockville, MD 20852, United States. Electronic address: mzlong@bop.gov.
Vaccine ; 39(40): 5883-5890, 2021 09 24.
Article in English | MEDLINE | ID: covidwho-1356481
ABSTRACT

OBJECTIVES:

To describe COVID-19 vaccine distribution operations in United States Federal Bureau of Prisons (BOP) institutions and offices from December 16, 2020-April 14, 2021, report vaccination coverage among staff and incarcerated people, and identify factors associated with vaccination acceptance among incarcerated people.

METHODS:

The BOP COVID-19 vaccination plan and implementation timeline are described. Descriptive statistics and vaccination coverage were calculated for the BOP incarcerated population using data from the BOP electronic medical record. Coverage among staff was calculated using data from the Centers for Disease Control and Prevention Vaccination Administration Management System. Vaccination coverage in the BOP versus the overall United States adult population was compared by state/territory. Univariate and multivariable logistic regression models were developed to identify demographic, health-related, and institution-level factors associated with vaccination acceptance among incarcerated people, using hierarchical linear modeling to account for institution-level clustering.

RESULTS:

By April 14, 2021, BOP had offered COVID-19 vaccination to 37,870 (100%) staff and 88,173/126,413 (69.8%) incarcerated people, with acceptance rates of 50.2% and 64.2%, respectively. At the time of analysis, vaccination coverage in BOP was comparable to coverage in the overall adult population in the states and territories where BOP institutions and offices are located. Among incarcerated people, factors associated with lower vaccination acceptance included younger age, female sex, non-Hispanic Black and Asian race/ethnicity, and having few underlying medical conditions; factors associated with higher acceptance included having a prior SARS-CoV-2 infection, being born outside the United States, and being assigned to a Federal Detention Center.

CONCLUSIONS:

Early COVID-19 vaccination efforts in BOP have achieved levels of coverage similar to the general population. To build on this initial success, BOP can consider strategies including re-offering vaccination to people who initially refused and tailoring communication strategies to groups with lower acceptance rates.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Adult / Female / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Adult / Female / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2021 Document Type: Article